The debate about the funding of Herceptin: A case study of ‘countervailing powers’
- 1 December 2012
- journal article
- Published by Elsevier in Social Science & Medicine
- Vol. 75 (12) , 2353-2361
Abstract
No abstract availableKeywords
Funding Information
- Health Research Council of New Zealand (08/256)
This publication has 30 references indexed in Scilit:
- ‘A pill for every ill’: Explaining the expansion in medicine useSocial Science & Medicine, 2010
- Partial Progress: Governing the Pharmaceutical Industry and the Nhs, 1948–2008Journal of Health Politics, Policy and Law, 2009
- How much will Herceptin really cost?BMJ, 2006
- Pills, Power, People: Sociological Understandings of the Pharmaceutical IndustrySociology, 2006
- Adjuvant trastuzumab for breast cancerBMJ, 2005
- Globalization and the Pharmaceutical Industry RevisitedInternational Journal of Health Services, 2003
- The role of the media in steering public opinion on healthcare issuesHealth Policy, 2003
- The system of alignments challenging physician professional dominance: an elaborated theory of countervailing powersSociology of Health & Illness, 2002
- Managing Pharmaceutical Expenditure while Increasing AccessPharmacoEconomics, 1999
- Halcion Nights: A Sociological Account of a Medical ControversySociology, 1996